resveratrol/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases visual analogue scale pain intensity
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Resveratrol treatment significantly reduced pain intensity and WOMAC scores, while increasing OKS scores, ROM, gait velocity, HGS, and overall SPPB performance (p < 0.05).”
Quoted verbatim from Resveratrol supplementation improves functional performance in knee osteoarthritis by upregulating sirtuin 1: a randomized study.. - Study
- RCT
- Duration
- 3 months
- Dose
- 500 mg/day
- Population
- Patients with knee osteoarthritis, aged 63-73 years, in a 12-week double-blind placebo-controlled trial (n=122 analyzed after dropouts: placebo n=65, resveratrol n=57)
Resveratrol supplementation improves functional performance in knee osteoarthritis by upregulating sirtuin 1: a randomized study.2025PMID:41037125Permalink
Keep reading
- Everything the graph holds on resveratrol
- Every compound studied against Visual analogue scale pain intensity
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M1ZAQF98P0HAS0BV6QTDP47X